XTSXNEWU
Market cap602kUSD
Dec 23, Last price
0.01CAD
1D
0.00%
1Q
-75.00%
IPO
-99.17%
Name
Newtopia Inc
Chart & Performance
Profile
Newtopia Inc., a health technology company, delivers disease prevention solutions. It offers a personalized habit change platform that focuses on physical and mental health risk reduction. The company was incorporated in 2008 and is headquartered in Toronto, Canada.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
Income | |||||||
Revenues | 9,784 -12.38% | 11,166 6.80% | 10,456 -8.41% | ||||
Cost of revenue | 11,818 | 17,389 | 17,419 | ||||
Unusual Expense (Income) | |||||||
NOPBT | (2,034) | (6,222) | (6,963) | ||||
NOPBT Margin | |||||||
Operating Taxes | 392 | 188 | |||||
Tax Rate | |||||||
NOPAT | (2,034) | (6,615) | (7,151) | ||||
Net income | (6,600) -14.29% | (7,700) 0.66% | (7,650) -1.06% | ||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | 1,726 | 3,136 | |||||
BB yield | -29.28% | ||||||
Debt | |||||||
Debt current | 8,491 | 7,777 | 2,632 | ||||
Long-term debt | 1,387 | 1,613 | 3,217 | ||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | 9,491 | 9,045 | 5,037 | ||||
Cash flow | |||||||
Cash from operating activities | (2,270) | (5,915) | (5,949) | ||||
CAPEX | (3) | (989) | (2,147) | ||||
Cash from investing activities | (3) | (989) | (2,147) | ||||
Cash from financing activities | 2,314 | 6,439 | 4,234 | ||||
FCF | (2,098) | (6,187) | (6,902) | ||||
Balance | |||||||
Cash | 387 | 346 | 812 | ||||
Long term investments | |||||||
Excess cash | 289 | ||||||
Stockholders' equity | (23,570) | (18,395) | (13,497) | ||||
Invested Capital | 24,029 | 21,708 | 16,833 | ||||
ROIC | |||||||
ROCE | |||||||
EV | |||||||
Common stock shares outstanding | 148,614 | 112,736 | 100,350 | ||||
Price | 0.10 -76.25% | 0.40 -49.37% | |||||
Market cap | 10,710 -73.32% | 40,140 -24.10% | |||||
EV | 19,755 | 45,177 | |||||
EBITDA | (1,052) | (5,938) | (6,712) | ||||
EV/EBITDA | |||||||
Interest | 1,595 | 392 | 188 | ||||
Interest/NOPBT |